Singapore’s sovereign wealth fund GIC and state investor Temasek have acquired a “significant stake” in the clinical research firm Novotech, which is majority-owned by private equity giant TPG.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
